Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Phio Pharmaceuticals Corp (PHIO)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 5,780,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3302 - $0.3302
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year    
 
Company Profile   Phio Pharmaceuticals is developing therapeutics that use its INTASYL™ technology to target both tumor and immune cells by regulating genes to strengthen a patient's immune system while weakening tumor defense mechanisms. Co.'s INTASYL-based therapeutics are used to: strengthen immune cells, for example those administered as part of adoptive cell therapy (ACT), and directly modify cells in the tumor microenvironment to weaken a tumor's defense. Co.'s lead product candidate being developed by Co. in ACT is PH-762. Co.'s second product candidate in development for use in ACT is PH-894. Co.'s INTASYL compound PH-804 is also being developed for use in ACT.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,500 6,500 22,216
Total Buy Value $0 $2,275 $14,195 $22,362
Total People Bought 0 1 2 2
Total Buy Transactions 0 1 4 12
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 238
  Page 9 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-06-28 4 D $0.20 $9,281 D/D (46,874) 39,947,559     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-06-27 4 D $0.19 $30,165 D/D (155,000) 39,994,433     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-06-26 4 D $0.20 $14,799 D/D (75,500) 40,149,433     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-06-25 4 D $0.19 $9,700 D/D (50,000) 40,224,933     -
   Galena Biopharma, Inc. 10% Owner   –       –       •   2013-05-02 4 S $0.19 $48,197 D/D (253,000) 32,393,095     -
   Galena Biopharma, Inc. 10% Owner   –       –       •   2013-05-01 4 S $0.19 $126,954 D/D (659,500) 32,646,095     -
   Galena Biopharma, Inc. 10% Owner   –       –       •   2013-04-30 4 S $0.21 $36,560 D/D (171,000) 33,305,595     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-21 4 D $0.23 $11,252 D/D (48,500) 39,684,265     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-20 4 D $0.23 $13,573 D/D (58,600) 39,732,765     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-19 4 D $0.30 $12,000 D/D (40,000) 39,791,365     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-18 4 D $0.35 $18,409 D/D (52,900) 39,831,365     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-15 4 D $0.33 $32,500 D/D (100,000) 39,884,265     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-14 4 D $0.33 $44,490 D/D (134,343) 39,984,265     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-12 4 D $0.27 $27,200 D/D (100,000) 40,118,608     -
   Opko Health, Inc. 10% Owner   –       –       •   2013-03-12 3 IO $0.00 $0 D/D 0 67,241,380     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-11 4 D $0.22 $96,700 D/D (400,000) 40,218,608     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-08 4 D $0.19 $9,700 D/D (50,000) 40,618,608     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-07 4 D $0.20 $9,750 D/D (50,000) 40,668,608     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-06 4 D $0.15 $5,449 D/D (36,570) 40,718,608     -
   Cauwenbergh Geert President & CEO   •       •      –    2013-03-06 4 A $0.15 $36,250 D/D 250,000 250,000     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-05 4 D $0.15 $4,350 D/D (30,000) 40,755,178     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-04 4 D $0.15 $7,250 D/D (50,000) 40,785,178     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-03 3 IO $0.00 $0 D/D 0 41,259,266     -
   Advanced Rna Technologies, Llc 10% Owner   –       –       •   2013-03-01 4 D $0.15 $3,000 D/D (20,000) 40,835,178     -
   Galena Biopharma, Inc. 10% Owner   –       –       •   2013-03-01 3 IO $0.00 $0 D/D 0 33,476,595     -
  238 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us